CClinicalTrials.gg
CompletedNCT05070572Updated Apr 29, 2026Results posted

Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output

An observational study in Intra-Abdominal Hypertension and Inguinal Hernia, sponsored by Antonios Likourezos. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Antonios Likourezos · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
21
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study serves as a pilot study with the intention to to measure intraabdominal pressure, lactic acid, and urine output in obese individuals undergoing laparoscopic inguinal hernia repair. By measuring these values, the investigators aim to look for correlations between metrics and determine an accurate and precise measurement of IAP during laparoscopic hernia surgery using the Accuryn Monitoring System. By obtaining accurate and precise measurements of IAP during surgery the investigators will be to compare measurements to previous IAP data obtained during daily activities and strenuous movements and any associations with inguinal hernia recurrence.

02

Conditions studied

  • Intra-Abdominal Hypertension
  • Inguinal Hernia
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population will be derived from the elective, outpatient surgical practice of the department of general surgery at Maimonides Medical Center.

Inclusion criteria

  • Obese with BMI > 30
  • Diagnosis of inguinal hernia
  • Qualify for laparoscopic inguinal hernia repair

Exclusion criteria

Exclusion Criteria:

  • Previous bowel resections resulting in short bowel
  • Extensive abdominal scarring
  • BMI \< 30
  • Fail to qualify for laparoscopic inguinal hernia repair
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
21 participants (actual)
Patient registry
No

Interventions

  • DeviceAccuryn Monitoring System

    Utilization of the Accuryn Monitoring System to measure intraabdominal pressure and urine output during laparoscopic inguinal hernia repair surgery.

05

What researchers measure

Primary outcomes

  1. Intraabdominal Pressure

    Maximum IAP levels during surgery

    Time frame: 2 hours

06

Results

Posted Apr 29, 2026

Participant flow

Participant flow — Overall Study
MilestoneInguinal Hernia Repair
Started21
Completed21
Not completed0

Outcome measures

PrimaryIntraabdominal Pressure

Maximum IAP levels during surgery

Time frame:
2 hours
Reported as:
Mean · mmHg
Intraabdominal Pressure
mmHgInguinal Hernia Repair
Intraabdominal Pressure25.58 ± 8.15

Adverse events

Collected over 2 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Inguinal Hernia Repair0/21 (0%)0/21 (0%)0/21 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Inguinal Hernia Repair
Mean58 ± 16.5
Sex: Female, Male
Sex: Female, Male(Participants)Inguinal Hernia Repair
Female0
Male21
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Inguinal Hernia Repair
Region of Enrollment
Region of Enrollment(participants)Inguinal Hernia Repair
United States21
07

Study locations

1 site
  • Maimonides Medical Center
    Brooklyn, New York 11219, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 4, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT05070572
Lead sponsor
Antonios Likourezos
Collaborators
Potrero Medical
Responsible party
Antonios Likourezos (Research Administration Director, Maimonides Medical Center) — Sponsor-investigator
First posted
Oct 7, 2021
Start date
Jan 1, 2021
Primary completion
Jan 31, 2023
Completion
Apr 30, 2023
Results posted
Apr 29, 2026
Last update
Apr 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion